Moreover, radiotherapy promotes CD8+-T-lymphocyte mediated tumour cell killing via ICAM-1 and MIC A/B so that inflammatory remodelling of the microenvironment leads to increased tumour cell death (reviewed by Donlon [34]). The gene discussed is ICAM1; the disease is neoplasm.